VeröffentlichungenDiatech Admin2020-10-20T12:07:57+02:00

Veröffentlichungen

Marktführer in Italien
bei der Vermarktung von diagnostischen Kits
für pharmakogenetische Tests

109, 2021

Carlotta Antoniotti et al., Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study

2508, 2021

Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype.

2408, 2021

Umberto Malapelle et al., Reference standards for gene fusion molecular assays on cytological samples: an international validation study.

2308, 2021

Martina Lorenzi et al., First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.

1908, 2021

Sabrina Rossi et al., Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC

508, 2021

Antonio Marchetti et al., Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network

2207, 2021

Alessandro Pancrazzi et al., Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response

2207, 2021

Pamela Trillo Aliaga et al., Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis.

1807, 2021

Alessandro Parisi et al., Clinicians‘ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, „Real-Life“, Case-Control Study

1307, 2021

Valentina Angerilli et al., Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas

107, 2021

Cristina Morelli et al., Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling

3006, 2021

Anello Marcello Poma et al., COVID-19 autopsy cases: detection of virus in endocrine tissues

Vorheriges 91011 Nächstes